Series A · Healthtech · Cambridge, United Kingdom · Founded 2015 · 25–50 employees
BIOS Health is pioneering neural digital therapies by developing AI-driven neural interfaces that can read and write neural data in real-time to treat chronic diseases. The company has built a proprietary neural data and AI platform that can precisely link nerve activity to specific conditions, potentially revolutionizing treatments for conditions like hypertension, diabetes, rheumatoid arthritis, Parkinson's and Alzheimer's. Founded by Cambridge University researchers, BIOS has raised $20M in Series A funding and was chosen by the NIH for the $21M REVEAL project - the largest ever clinical study of human neural data - alongside Stanford, Mayo Clinic and University of Minnesota. The company represents a potential "Human Genome Project" equivalent for the nervous system, positioning itself as a foundational platform for precision medicine in the neural space.
No open roles listed right now.